IMMUNICUM.COM

Home - Immunicum

Immunicum is listed on NASDAQ OMX First North under the ticker IMMU. Clinical Phase I/II-trial (RCC). INTUVAX -HCC (liver cancer). Immunicum AB (publ), a clinical phase II company, develops cancer immunotherapies. The Company’s two main groups of therapeutic cancer vaccines, in addition to the method for expansion of tumor-specific T-cells, are based on many years of research within the area of transplantation immunology. Press releases, financial reports, calendar, meetings/presentations, etc.

http://www.immunicum.com/

OVERVIEW OF immunicum.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

4

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR IMMUNICUM.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

November

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Sunday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 3.6 out of 5 with 11 reviews

5 star

3

4 star

3

3 star

4

2 star

0

1 star

1

Hey there! Start your review of immunicum.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

CONTACTS AT IMMUNICUM.COM

CK Network AB

Mikael Fougelberg

Fac●●●369

Up●●la , 751 75

SWEDEN

4670●●●●9791

4631●●●●8104

su●●●●●@cknetwork.se

View this contact

CK Network AB

Mikael Fougelberg

Fac●●●369

Up●●la , 751 75

SWEDEN

4670●●●●9791

4631●●●●8104

su●●●●●@cknetwork.se

View this contact

CK Network AB

Mikael Fougelberg

Fac●●●369

Up●●la , 751 75

SWEDEN

4670●●●●9791

4631●●●●8104

su●●●●●@cknetwork.se

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2007 October 17
UPDATED: 2013 April 10
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

17

YEARS
9

MONTHS
14

DAYS

NAME SERVERS

1: ns1.cknetwork.se
2: ns2.cknetwork.se
3: ns3.cknetwork.se

REGISTRAR

DOMAININFO AB D/B/A DOMAININFO.COM

WHOIS : whois.domaininfo.com

REFERRED : http://www.domaininfo.com

CONTENT

PAGES IN
THIS WEBSITE

4

SSL

EXTERNAL LINKS

4

SITE IP

89.221.241.34

LOAD TIME

0 sec

SCORE

6.2

PAGE TITLE

Home - Immunicum | immunicum.com Reviews

<META> DESCRIPTION

Immunicum is listed on NASDAQ OMX First North under the ticker IMMU. Clinical Phase I/II-trial (RCC). INTUVAX -HCC (liver cancer). Immunicum AB (publ), a clinical phase II company, develops cancer immunotherapies. The Company’s two main groups of therapeutic cancer vaccines, in addition to the method for expansion of tumor-specific T-cells, are based on many years of research within the area of transplantation immunology. Press releases, financial reports, calendar, meetings/presentations, etc.

<META> KEYWORDS

1 choose language

2 immunicum

3 menu

4 sub menu

5 strategy

6 history

7 organization

8 board of directors

9 management

10 scientific advisory board

CONTENT

Page content here

KEYWORDS ON PAGE

choose language,immunicum,menu,sub menu,strategy,history,organization,board of directors,management,scientific advisory board,technology,platforms,the combig platform,intuvax,subcuvax,the cd70 platform,adenovirus vector,intellectual property rights,news

SERVER

Apache

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Home - Immunicum | immunicum.com Reviews

https://immunicum.com

Immunicum is listed on NASDAQ OMX First North under the ticker IMMU. Clinical Phase I/II-trial (RCC). INTUVAX -HCC (liver cancer). Immunicum AB (publ), a clinical phase II company, develops cancer immunotherapies. The Company’s two main groups of therapeutic cancer vaccines, in addition to the method for expansion of tumor-specific T-cells, are based on many years of research within the area of transplantation immunology. Press releases, financial reports, calendar, meetings/presentations, etc.

SUBDOMAINS

ir.immunicum.com

Immunicum AB - Investerare

Företrädesemission - läs mer. Ladda ner prospekt. Klinisk Fas I/II-studie (RCC). Välkommen till Immunicums investerarsidor! Här presenteras information som kan vara av intresse för Bolagets aktieägare, analytiker och andra intressenter. För ytterligare information eller frågor kontakta VD Jamal El-Mosleh. Jamal El-Mosleh, VD. Tel: 031- 41 50 53. E-post: jamal.el-mosleh@immunicum.com. Visa alla meddelanden ». 13 augusti, 2015. Magnus Persson föreslås till ny styrelseledamot i Immunicum. 5 augusti, 2015.

INTERNAL PAGES

immunicum.com

1

Pipeline | Immunicum

http://www.immunicum.com/pipeline

Events & Webcast. Call for General Meeting. Events & Webcast. Call for General Meeting. Choose which language you would like to receive the press release in:. 46 31 41 50 52. We use cookies to improve the user experience on Immunicum. Read more about Cookies.

2

CD70 | Immunicum

http://www.immunicum.com/pipeline/cd70

Events & Webcast. Call for General Meeting. Events & Webcast. Call for General Meeting. Choose which language you would like to receive the press release in:. 46 31 41 50 52. We use cookies to improve the user experience on Immunicum. Read more about Cookies.

3

News | Immunicum

http://www.immunicum.com/news

Events & Webcast. Call for General Meeting. Events & Webcast. Call for General Meeting. CD70 patent in China. Immunicum announces that a patent application in China regarding the Company’s CD70-technology will be granted. Press release 160726… Read more. Immunicum today announced that the Company has submitted an Investigational New Drug (IND) application to the Food and Drug… Read more. Positive update – survival data in RCC phase I/II. Partnership with Accelovance and MMP for US studies. In the exercis...

4

Partnering | Immunicum

http://www.immunicum.com/partnering

Events & Webcast. Call for General Meeting. Events & Webcast. Call for General Meeting. Together we are stronger. Join us in our journey towards transforming cancer treatment. With promising clinical data at hand, we are continuously evaluating collaborations and license agreements with key partners in academia the pharmaceutical/biotech industry. We are devoted to maximizing the commercial and therapeutic potential of our research in immunooncology. By combining our internal expertise and techno...Rutge...

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL PAGES IN THIS WEBSITE

4

LINKS TO THIS WEBSITE

dtanalysts.com

Immunicum announces INTUVAX phase I/II data at ASCO 2014 | Diagnostic and Defense Technology Analysts

http://www.dtanalysts.com/node/24

Immunicum announces INTUVAX phase I/II data at ASCO 2014. Tue, 06/10/2014 - 16:39 POSTED BY. Immunicum AB, a bio-pharmaceutical company developing therapeutic. Cancer vaccines, today announced that phase I/II data has been presented. During a general poster session at the American Society of Clinical Oncology. ASCO) 2014 annual meeting on the Company’s clinical candidate, INTUVAX, in. Patients with metastasized renal cell carcinoma (mRCC). Tumor for vaccine-induced cytotoxic T cells via a well-documented...

phantas.se

Foreign Investors :: Phantas

http://www.phantas.se/ovrigt/foreign-investors

Bevakning av Hansa Medical, Wilson Therapeutics and Immunicum. Immunicum is a Swedish Biotech Company listed on NASDAQ OMX First North and develops therapeutic cancer vaccines with INTUVAX being their flagship model. The company has a total of five projects in their pipeline and their main cancer vaccine, INTUVAX, currently recruiting 90 patients for a clinical phase II study for kidney cancer (Renal Cell Carcinoma). Company webpage: www.immunicum.com. 2016 november - Uppdaterad värdering.

UPGRADE TO PREMIUM TO VIEW 2 MORE

TOTAL LINKS TO THIS WEBSITE

4

OTHER SITES

immunicity.uk

Immunicity | Custom PAC Proxies

Create a local Tor Proxy. Create a SOCKS5 Proxy. Bypassing UK Internet Censorship. This platform enables those in the UK with censored. Internet connections to bypass. These filters by building customised PAC files to selectively route certain websites via uncensored proxies. This service is provided for free. And without adverts. Please be considerate and don't stream across the public proxies but instead use a local Tor proxy. Or your own SOCKS5 proxy. Create Your PAC File. Navigate to the Create.

immunicity.world

Access Your Favourite Blocked Sites @ www.immunicity.world

Torrent Sites - Seeders and Leechers Paradise! Top Streaming Sites - Find the latest Movies and TVShows! Best Download Sites - For all your needs! Major Music Sites - Download your Music for Free! EBooK and Magazines - Knowledge must be FREE! Adult Sites, 18 only! Same content, different mirrors. You're welcome to Share them! This site does NOT store any files on its server. We only index and link to content provided by other sites! We are TOR Friendly! Is about Circumventing Internet Censorship.

immunicode.com

The domain immunicode.com is for sale. To purchase, call Afternic.com at 1 781-373-6847 or 855-201-2286. Click here for more details.

immunicon.com

Venta de pisos en Madrid | La más completa oferta de pisos en Madrid, inserta tu anuncio gratis.

Buscar apartamento en venta. Pisos en venta Madrid. Vender piso en Internet. TÉCNICAS PARA VENDER UN PISO EN LA CIUDAD DE MADRID. VENDER RÁPIDO Y SEGURO. Empieza por poner Anuncios Inmobiliarios. En muchos portales simultáneamente, de esta forma incrementas las posibilidades de vender tu casa. Ya que tu anuncio llega a mucha más gente que visita Inmobiliarias en Madrid. Así como portales de la ciudad. La mejor publicidad Inmobiliaria. Vender piso en Madrid. INTERNET COMO HERRAMIENTA PUBLICITARIA. En Espa...

immunicorp.com

The Sponsored Listings displayed above are served automatically by a third party. Neither the service provider nor the domain owner maintain any relationship with the advertisers. In case of trademark issues please contact the domain owner directly (contact information can be found in whois).

immunicum.com

Home - Immunicum

Immunicum is listed on NASDAQ OMX First North under the ticker IMMU. Clinical Phase I/II-trial (RCC). INTUVAX -HCC (liver cancer). Immunicum AB (publ), a clinical phase II company, develops cancer immunotherapies. The Company’s two main groups of therapeutic cancer vaccines, in addition to the method for expansion of tumor-specific T-cells, are based on many years of research within the area of transplantation immunology. Press releases, financial reports, calendar, meetings/presentations, etc.

immunicum.se

Immunicum | Innovation in immuno-oncology

Events & Presentations. Remuneration and the remuneration committee. Auditors and audit committee. Shareholder & Stock Info. SECURED RIGHTS ISSUE 2017. Events & Presentationer. News & Events. Immunicum in the News. Events & Presentations. Remuneration and the remuneration committee. Auditors and audit committee. Shareholder & Stock Info. SECURED RIGHTS ISSUE 2017. Events & Presentationer. News & Events. Immunicum in the News. Please join IMMUNICUM at our. April 2018 Investor Events. We are on a journey t...

immunicure.com

www.immunicure.com

This Web page parked FREE courtesy of LXVI. Search for domains similar to. Is this your domain? Let's turn it into a website! Would you like to buy this. Find Your Own Domain Name. See our full line of products. Easily Build Your Professional Website. As low as $4.99/mo. Call us any time day or night (866) 598-4638.

immunicyte.com

Immunicyte.com

immunid-blog.com

平常心日常の色々 – Just another WordPress site

Just another WordPress site. 資生堂から出ているザコラーゲンという商品です。 2018 平常心日常の色々 · Powered by WordPress. Middot; テーマ: Germaine by Glam.Ink.

immunid.com

Home | ImmunID

Skip to main content. Scientific and Medical Advisory Board. Infectious Diseases and Related Disorders. Immune Diagnostics To Guide Therapeutic Choices. ImmunID: personalized medicine based on the immune status. Immune status to advance personalized medicine. Characterize, visualize, and quantify immune repertoires. Scancell collaboration with ImmunID. Inching closer. #SC. I am feeling ultra optimistic that Scancell is going. The final pieces of the jigsaw on an incredible journey and.